EigenLayer's EIGEN came out in late 2024 but fell to an all-time low in March 2025. It is currently working with UMA and ...

Bionexus Gene Lab Corporation was the first Nasdaq-listed company Ethereum (ETH) to Bitcoin (BTC) chosen as strategic ...

BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BTC rallies on tariff delay & conference optimism. BTC sentiment still in ‘Extreme Fear’. Coinbase plans to offer tokenised securities. New Hampshire BTC bill passes House committee. Falling USD ...

KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a ...

Additionally, BioNexus sees Ethereum’s deep integration in the global financial ecosystem as a key factor. The Ethereum ...

Ethereum’s bullish momentum continues, driven by the Pectra upgrade and BioNexus announcement, pushing ETH towards a potential $3000 ...

Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other features as reasons to choose ...

BioNexus Gene Lab becomes the first Nasdaq-listed company to adopt Ethereum as its primary treasury asset. Ethereum’s versatility, high liquidity, and Proof-of-Stake rewards make it ideal for ...

Ethereum [ETH] ETF flows turned positive after 10 days of an outflow trend, signaling a likely renewed demand for the altcoin. On the 4th of March, the products logged $14.58M inflows, and marched ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH Whitepaper.